Strategic modification of low-activity natural antimicrobial peptides confers antibacterial potential in vitro and in vivo

Prakash Kishore Hazam,Chih-Cheng Cheng,Wen-Chun Lin,Chu-Yi Hsieh,Po-Hsien Hsu,Yun-Ru Chen,Chao-Chin Li,Po-Ren Hsueh,Jyh-Yih Chen
DOI: https://doi.org/10.1016/j.ejmech.2023.115131
IF: 7.088
2023-01-20
European Journal of Medicinal Chemistry
Abstract:Antimicrobial peptides (AMPs) show great promise for clinical applications, but the utility of naturally occurring AMPs is often limited by their stability. Here, we used a rational design approach to improve the characteristics of a pair of inactive peptides, tilapia piscidin 1 and 2 (TP1 and TP2). From each starting peptide, we generated a series of novel derivatives by substituting residues to adjust cationic charge density, percent hydrophobicity and hydrophilicity/hydrophobicity coefficients. This approach yielded a novel peptide, TP2-5 (KKCIAKAILKKAKKLLKKLVNP), that exhibits significant bactericidal potency, low cytotoxicity and high stability. The designed peptide further showed antibiofilm activity, rapid antibacterial action and a low capacity to induce bacterial resistance. Importantly, we also demonstrated that TP2-5 can protect mice in a Vibrio vulnificus -infected wound model. Therefore, our peptide modification strategy successfully generated a novel AMP with high potential for future clinical application.
chemistry, medicinal
What problem does this paper attempt to address?